Indivior PLC (FRA:2IVB)
€ 9.9 1.2 (13.79%) Market Cap: 1.21 Bil Enterprise Value: 1.18 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 64/100

Full Year 2018 Indivior PLC Earnings Call Transcript

Feb 14, 2019 / 11:30AM GMT
Release Date Price: €6.33 (+0.16%)
Shaun Thaxter
Indivior PLC - CEO & Executive Director

Okay. Good morning, everybody, and welcome to the full year results for 2018 for Indivior. My name is Shaun Thaxter. I am the Chief Executive Officer, and I'm looking forward today with my colleagues, Mark Crossley, Chief Financial Officer; Javier Rodriguez, Chief Legal Officer; and Christian Heidbreder, Chief Scientific Officer to sharing with you the results from last year, our plans for this year as we continue to pursue our journey towards our vision to ensure that patients all around the world have unrestricted access to evidence-based treatments for the chronic relapsing conditions and the co- occurring disorders of addiction.

I will assume that you've read the forward-looking statements. And our agenda today is I will give an overview, then Mark will give a financial report, we'll have a legal update, and then we'll look at some new exciting scientific data on progress that's been made in our R&D and medical functions last year.

Well, clearly, 2018 was a challenging year with net revenues dropping from the prior year.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot